Preclinical Evaluation of INS1201 AAV9-Micro-Dystrophin Via CSF Administration as a Potential Therapy for Duchenne Muscular Dystrophy INS1201 is an investigational adeno-associated virus 9–micro-dystrophin gene transfer therapy under development as a potential treatment for Duchenne muscular dystrophy (DMD). Administered into the ce...

New #moltherapyadvances paper: Preclinical Evaluation of INS1201 AAV9-Micro-Dystrophin Via CSF Administration as a Potential Therapy for Duchenne Muscular Dystrophy. #Myoblue tinyurl.com/3633sxmx